Dimitrios Mavroudis

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

N. Young, A. Barrett, J. Tisdale, 1998, Bone Marrow Transplantation.

The graft-versus-leukemia effect.

J. Barrett, V. Malkovska, Dimitrios Mavroudis, 1996, Current opinion in oncology.

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.

C. Dunbar, D. Couriel, J. Barrett, 1996, Blood.

Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactions

Raptis, Fellowes, N. Hensel, 1998, British journal of haematology.

Interaction of natural killer cells with MHC class II: reversal of HLA‐DR1‐mediated protection of K562 transfectant from natural killer cell‐mediated cytolysis by brefeldin‐A

A. Barrett, N. Hensel, D. Couriel, 1996, Immunology.

Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation.

I. Pastan, A. Barrett, N. Hensel, 1996, Bone marrow transplantation.

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

A. Raptis, R. Childs, A. Suffredini, 1999, Bone Marrow Transplantation.

Preferential usage of T cell receptor (TCR) V β by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease

N. Hensel, S. Dermime, J. Molldrem, 1997, Bone Marrow Transplantation.